Dialysis News and Research RSS Feed - Dialysis News and Research

When your kidneys are healthy, they clean your blood. They also make hormones that keep your bones strong and your blood healthy. When your kidneys fail, you need treatment to replace the work your kidneys used to do. Unless you have a kidney transplant, you will need a treatment called dialysis.

There are two main types of dialysis: hemodialysis and peritoneal dialysis. Both types filter your blood to rid your body of harmful wastes, extra salt and water. Hemodialysis does that with a machine. Peritoneal dialysis uses the lining of your abdomen, called the peritoneal membrane, to filter your blood. Each type has both risks and benefits. They also require that you follow a special diet. Your doctor can help you decide the best type of dialysis for you.
Older patients feel voiceless in decision-making process for dialysis, study finds

Older patients feel voiceless in decision-making process for dialysis, study finds

Starting dialysis treatment for end-stage renal disease (ESRD) should be a shared decision made by an informed patient based on discussions with a physician and family members. [More]
Study finds tight glycemic control provides no impact on patient-important microvascular outcomes

Study finds tight glycemic control provides no impact on patient-important microvascular outcomes

The glucocentric focus on lowering blood sugar in Type 2 diabetes may have short-circuited development of new diabetes therapies, according to a new paper published by Mayo Clinic researchers in the journal Circulation: Cardiovascular Quality and Outcomes. [More]
DASH-style diet could help lower risk of developing chronic kidney disease

DASH-style diet could help lower risk of developing chronic kidney disease

People who ate a diet high in nuts and legumes, low-fat dairy, whole grains, fruits, and vegetables and low in red and processed meat, sugar-sweetened beverages and sodium were at a significantly lower risk of developing chronic kidney disease over the course of more than two decades, new Johns Hopkins Bloomberg School of Public Health research suggests. [More]
Study finds no major difference in effectiveness of two classes of drugs in peritoneal dialysis patients

Study finds no major difference in effectiveness of two classes of drugs in peritoneal dialysis patients

With cardiovascular disease being the No. 1 cause of death in end-stage kidney disease patients on peritoneal dialysis, a new study examined two classes of medications commonly prescribed to prevent cardiovascular events in these patients and found no significant difference in outcomes. [More]
Stranger’s organ donation instigates six-way kidney swap

Stranger’s organ donation instigates six-way kidney swap

A stranger began a chain of events that eventually saved the lives of six people in desperate need of new kidneys. Her organ donation triggered a six-way kidney swap at Houston Methodist Hospital in July, the second largest of its kind performed at one institution in Texas. [More]

Burkert’s new micro-valve Type 6712 sets new standard in speed, size and acoustic volume

With a width of just 7 mm and a height of 26 mm, the new micro-valve fits in miniature apparatus. [More]
Smoking reduces lifespans and overall chances of kidney transplantation in dialysis patients

Smoking reduces lifespans and overall chances of kidney transplantation in dialysis patients

Dialysis patients who smoke are much less likely to receive a life-saving kidney transplant and much more likely to die sooner according to researchers from the Health Research Institute (HRI) at the University of Limerick and UL’s Graduate Entry Medical School. [More]
Retained metabolites may contribute to impaired cognitive function in kidney failure patients

Retained metabolites may contribute to impaired cognitive function in kidney failure patients

Retention of certain metabolites in the blood may contribute to cognitive impairment in patients with kidney failure, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. [More]
AJCC article outlines role of LTAC hospitals in health care continuum

AJCC article outlines role of LTAC hospitals in health care continuum

Advances in technology have helped more patients survive acute illness and trauma, and these patients are increasingly transferred to long-term acute care hospitals. [More]
Red meat intake may increase risk of developing end-stage renal disease

Red meat intake may increase risk of developing end-stage renal disease

A new study indicates that red meat intake may increase the risk of kidney failure in the general population, and substituting red meat with alternative sources of protein from time to time may significantly reduce this risk. [More]
Two new studies find potential genetic cause and new treatment method for autoimmune diseases

Two new studies find potential genetic cause and new treatment method for autoimmune diseases

The American Autoimmune Related Diseases Association, Inc. is spotlighting two new research studies originally reported in ScienceDaily. [More]
FDA approves new ExAblate Neuro to treat patients with essential tremor

FDA approves new ExAblate Neuro to treat patients with essential tremor

The U.S. Food and Drug Administration today approved the first focused ultrasound device to treat essential tremor in patients who have not responded to medication. ExAblate Neuro uses magnetic resonance (MR) images taken during the procedure to deliver focused ultrasound to destroy brain tissue in a tiny area thought to be responsible for causing tremors. [More]
Innovative organ donation program allows living donors to donate kidney in advance

Innovative organ donation program allows living donors to donate kidney in advance

Gift certificate, layaway plan or voucher. Call it what you want, but an innovative organ donation program initiated at UCLA has started to spread to other transplant programs across the United States. [More]
New strategy treats fatal autoimmune disease without outward off-target effects

New strategy treats fatal autoimmune disease without outward off-target effects

In a study with potentially major implications for the future treatment of autoimmunity and related conditions, scientists from the Perelman School of Medicine at the University of Pennsylvania have found a way to remove the subset of antibody-making cells that cause an autoimmune disease, without harming the rest of the immune system. [More]
Study links alpha-defensin genes to IgA nephropathy risk

Study links alpha-defensin genes to IgA nephropathy risk

A gene which forms part of our body's first line of defence against infection may be associated with an increased risk with a type of kidney disease, research involving academics at The University of Nottingham has discovered. [More]
Virtual tissue technology helps identify new drug target to combat polycystic kidney disease

Virtual tissue technology helps identify new drug target to combat polycystic kidney disease

Using virtual tissue technology, researchers at Indiana University have identified a potential new drug target in the fight against polycystic kidney disease, an illness with no effective FDA-approved treatment that affects 200,000 people per year in the United States. [More]
Hyde Park artist draws daily creative inspiration from chronic health experience

Hyde Park artist draws daily creative inspiration from chronic health experience

A kidney transplantation means much more than good health to Jason E. Jones. The 53 year-old Hyde Park artist and Loyola Medicine patient draws daily creative inspiration from his chronic health experience. [More]
CD Laboratory at MedUni Vienna explores new therapeutic approaches to enhance peritoneal dialysis

CD Laboratory at MedUni Vienna explores new therapeutic approaches to enhance peritoneal dialysis

One of the main functions of the kidneys is to filter metabolic products out of the blood. If the kidneys are no longer able to do this, the blood has to be artificially purified and drained of excess fluid. [More]
New CAR-based therapy using combined cancer target could be effective for solid tumors

New CAR-based therapy using combined cancer target could be effective for solid tumors

Chimeric antigen receptors (CARs), engineered from a patient's own immune cells, have been successful for treating blood cancers, but using CARs for solid tumors has been limited by side effects to normal tissues containing the protein targeted by the engineered cells. [More]
Kidney transplant recipients with inflammation prior to surgery more likely to develop diabetes

Kidney transplant recipients with inflammation prior to surgery more likely to develop diabetes

Up to 30 percent of people who receive organ transplants will develop diabetes, but researchers are unsure why. Although doctors typically blame immunosuppressive drugs that transplant recipients take to prevent organ rejection, it's unclear why some people develop the lifelong disorder, while others do not. [More]
Advertisement
Advertisement